6-KThe Wire
Evogene Ltd. files 6-K
Filed Feb 4, 2026 · 5mo ago · Accession 0001178913-26-000299
Plain English
Evogene Ltd. announced that its subsidiary, Biomica Ltd., entered into an exclusive worldwide licensing agreement with Shanghai Lishan Biopharmaceuticals Co., Ltd. for BMC128, a microbiome-based therapeutic. Biomica is eligible to receive development and sales milestones payments, as well as royalties.
Filing details
- Company
- Evogene Ltd.
- Ticker
- EVGN
- CIK
- 1574565
- Form type
- 6-K
- Filing date
- Feb 4, 2026
- Report date
- Feb 4, 2026
- Document
- zk2634287.htm
- Size
- 104 KB